Indrani Nandy

2.4k total citations · 1 hit paper
33 papers, 1.6k citations indexed

About

Indrani Nandy is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Surgery. According to data from OpenAlex, Indrani Nandy has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 5 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Indrani Nandy's work include Prostate Cancer Diagnosis and Treatment (6 papers), Prostate Cancer Treatment and Research (6 papers) and Pelvic floor disorders treatments (3 papers). Indrani Nandy is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (6 papers), Prostate Cancer Treatment and Research (6 papers) and Pelvic floor disorders treatments (3 papers). Indrani Nandy collaborates with scholars based in United States, Canada and France. Indrani Nandy's co-authors include Terry C. Davis, Connie L. Arnold, Hans J. Berkel, Paul Siami, Francesco Montorsi, Ronaldo Damião, Kim Major‐Walker, Claus G. Roehrborn, R. Paul Gagnier and Betsy Morrill and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Neurology.

In The Last Decade

Indrani Nandy

32 papers receiving 1.6k citations

Hit Papers

The Effects of Combination Therapy with Dutasteride and T... 2009 2026 2014 2020 2009 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Indrani Nandy United States 16 568 547 320 277 234 33 1.6k
Lauren P. Wallner United States 28 299 0.5× 430 0.8× 254 0.8× 300 1.1× 199 0.9× 130 2.0k
Mikkel Fode Denmark 23 400 0.7× 422 0.8× 209 0.7× 251 0.9× 266 1.1× 143 2.0k
Michael J. Naslund United States 25 969 1.7× 1.1k 1.9× 519 1.6× 83 0.3× 262 1.1× 78 2.1k
Öner Şanlı Türkiye 23 336 0.6× 515 0.9× 246 0.8× 79 0.3× 643 2.7× 91 2.3k
Joshua A. Halpern United States 24 182 0.3× 554 1.0× 89 0.3× 102 0.4× 230 1.0× 132 1.7k
É. Huyghe France 22 175 0.3× 325 0.6× 292 0.9× 119 0.4× 416 1.8× 146 2.0k
Shari Goldfarb United States 26 352 0.6× 387 0.7× 120 0.4× 128 0.5× 242 1.0× 96 3.1k
A. Prins Netherlands 21 249 0.4× 124 0.2× 209 0.7× 115 0.4× 211 0.9× 25 1.2k
Azad Hassan Abdul Razack Malaysia 18 226 0.4× 257 0.5× 192 0.6× 69 0.2× 129 0.6× 97 1.1k
Li‐Jung Tseng United States 23 476 0.8× 321 0.6× 188 0.6× 34 0.1× 124 0.5× 76 1.8k

Countries citing papers authored by Indrani Nandy

Since Specialization
Citations

This map shows the geographic impact of Indrani Nandy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Indrani Nandy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Indrani Nandy more than expected).

Fields of papers citing papers by Indrani Nandy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Indrani Nandy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Indrani Nandy. The network helps show where Indrani Nandy may publish in the future.

Co-authorship network of co-authors of Indrani Nandy

This figure shows the co-authorship network connecting the top 25 collaborators of Indrani Nandy. A scholar is included among the top collaborators of Indrani Nandy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Indrani Nandy. Indrani Nandy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dunbar, Joi, et al.. (2024). Effects of zuranolone on next-day simulated driving in healthy adults. Psychopharmacology. 242(2). 389–400. 1 indexed citations
2.
Dunbar, Joi, David P. Walling, Rakesh K. Jain, et al.. (2024). Cognitive effects, pharmacokinetics, and safety of zuranolone administered alone or with alprazolam or ethanol in healthy adults in a phase 1 trial. Journal of Psychopharmacology. 38(12). 1122–1136. 1 indexed citations
3.
Clayton, Anita H., Robert Lasser, Indrani Nandy, et al.. (2023). Zuranolone in Major Depressive Disorder. The Journal of Clinical Psychiatry. 84(2). 50 indexed citations
4.
Cutler, Andrew J., Scott T. Aaronson, Gregory W. Mattingly, et al.. (2021). Zuranolone in Major Depressive Disorder: Interim Safety Results From a Phase 3, Open-Label, Longitudinal Study. Biological Psychiatry. 89(9). S161–S161. 1 indexed citations
5.
Cutler, Andrew J., Scott T. Aaronson, Gregory W. Mattingly, et al.. (2021). P.0672 Zuranolone 30 mg in major depressive disorder: results through 1-year follow-up from the Phase 3, open-label, SHORELINE study. European Neuropsychopharmacology. 53. S492–S493. 2 indexed citations
6.
Clayton, Anita H., Robert Lasser, Indrani Nandy, et al.. (2020). SAGE-217 in Major Depressive Disorder: A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial (705). Neurology. 94(15_supplement). 1 indexed citations
7.
Werneburg, Brian, Anita H. Clayton, Robert Lasser, et al.. (2020). P.305 The GABAA receptor positive allosteric modulator zuranolone in major depressive disorder: a double-blind, randomized, placebo-controlled phase 3 trial. European Neuropsychopharmacology. 40. S176–S177. 1 indexed citations
8.
Fleshner, Neil, M. Scott Lucia, Blair Egerdie, et al.. (2012). Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial. The Lancet. 379(9821). 1103–1111. 134 indexed citations
9.
11.
Roehrborn, Claus G., Paul Siami, Jack Barkin, et al.. (2009). The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study. European Urology. 57(1). 123–131. 528 indexed citations breakdown →
12.
Arnold, Connie L., Terry C. Davis, Hans J. Berkel, et al.. (2001). Smoking Status, Reading Level, and Knowledge of Tobacco Effects among Low-Income Pregnant Women. Preventive Medicine. 32(4). 313–320. 138 indexed citations
13.
Gholson, Charles F., et al.. (1998). Suspected Biliary Complications After Laparoscopic and Open Cholecystectomy Leading to Endoscopic Cholangiography A Retrospective Comparison. Digestive Diseases and Sciences. 43(3). 534–539. 5 indexed citations
14.
Zibari, Gazi B., et al.. (1998). Surgical and nonsurgical management of primary and metastatic liver tumors.. PubMed. 64(3). 211–20; discussion 220. 27 indexed citations
15.
Jur̀čovičová, Jana, et al.. (1998). Expression of platelet-derived growth factor-A mRNA in human placenta: Effect of magnesium infusion in pre-eclampsia. Placenta. 19(5-6). 423–427. 11 indexed citations
16.
Davis, Terry C., Connie L. Arnold, Indrani Nandy, et al.. (1997). Tobacco use among male high school athletes. Journal of Adolescent Health. 21(2). 97–101. 50 indexed citations
17.
Marchetti, Francesco, John B. Mailhes, Lee Bairnsfather, Indrani Nandy, & Steve N. London. (1996). Dose-response study and threshold estimation of griseofulvin-induced aneuploidy during female mouse meiosis I and II. Mutagenesis. 11(2). 195–200. 27 indexed citations
18.
Singh, Krishna B., et al.. (1996). Laparoscopic Tubal Sterilization in Obese Women: Experience From a Teaching Institution. Southern Medical Journal. 89(1). 56–59. 16 indexed citations
19.
Sullivan, William G., et al.. (1996). Flexible Fiberoptic Rhinoscopy in the Diagnosis of Nasal Polyps in Cystic Fibrosis. Allergy and Asthma Proceedings. 17(5). 287–292. 3 indexed citations
20.
Ampil, Federico L., et al.. (1996). Metastatic Disease in the Cerebellum. American Journal of Clinical Oncology. 19(5). 509–511. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026